BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 32979727)

  • 1. Alleviating tumor hypoxia with perfluorocarbon-based oxygen carriers.
    Krafft MP
    Curr Opin Pharmacol; 2020 Aug; 53():117-125. PubMed ID: 32979727
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recent Advances in Perfluorocarbon-Based Delivery Systems for Cancer Theranostics.
    Yang Y; Liu Y; Jiang Y
    Mol Pharm; 2023 Jul; 20(7):3254-3277. PubMed ID: 37318162
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic oxygen delivery by perfluorocarbon-based colloids.
    Krafft MP; Riess JG
    Adv Colloid Interface Sci; 2021 Aug; 294():102407. PubMed ID: 34120037
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional ultrasound-triggered phase-shift perfluorocarbon nanodroplets for cancer therapy.
    Guo R; Xu N; Liu Y; Ling G; Yu J; Zhang P
    Ultrasound Med Biol; 2021 Aug; 47(8):2064-2079. PubMed ID: 33992473
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Perfluorocarbon nanodroplets can reoxygenate hypoxic tumors
    Xiang Y; Bernards N; Hoang B; Zheng J; Matsuura N
    Nanotheranostics; 2019; 3(2):135-144. PubMed ID: 31008022
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TaOx decorated perfluorocarbon nanodroplets as oxygen reservoirs to overcome tumor hypoxia and enhance cancer radiotherapy.
    Song G; Ji C; Liang C; Song X; Yi X; Dong Z; Yang K; Liu Z
    Biomaterials; 2017 Jan; 112():257-263. PubMed ID: 27768978
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oxygen therapeutic agents to target hypoxia in cancer treatment.
    Spiess BD
    Curr Opin Pharmacol; 2020 Aug; 53():146-151. PubMed ID: 33086188
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fluorinated Hyaluronic Acid Encapsulated Perfluorocarbon Nanoparticles as Tumor-Targeted Oxygen Carriers to Enhance Radiotherapy.
    Wang W; Wang X; Tao F; Hu K; Zhang J; Wu J; You L; Zhao W
    Mol Pharm; 2022 Nov; 19(11):3948-3958. PubMed ID: 36194775
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Two-stage oxygen delivery for enhanced radiotherapy by perfluorocarbon nanoparticles.
    Zhou Z; Zhang B; Wang H; Yuan A; Hu Y; Wu J
    Theranostics; 2018; 8(18):4898-4911. PubMed ID: 30429876
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oxygenated theranostic nanoplatforms with intracellular agglomeration behavior for improving the treatment efficacy of hypoxic tumors.
    Zhou J; Xue C; Hou Y; Li M; Hu Y; Chen Q; Li Y; Li K; Song G; Cai K; Luo Z
    Biomaterials; 2019 Mar; 197():129-145. PubMed ID: 30641264
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic applications of lipid-coated microbubbles.
    Unger EC; Porter T; Culp W; Labell R; Matsunaga T; Zutshi R
    Adv Drug Deliv Rev; 2004 May; 56(9):1291-314. PubMed ID: 15109770
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High Intensity Focused Ultrasound-Responsive and Ultrastable Cerasomal Perfluorocarbon Nanodroplets for Alleviating Tumor Multidrug Resistance and Epithelial-Mesenchymal Transition.
    Ma X; Yao M; Shi J; Li X; Gao Y; Luo Q; Hou R; Liang X; Wang F
    ACS Nano; 2020 Nov; 14(11):15904-15918. PubMed ID: 33175487
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Perfluorocarbons: A perspective of theranostic applications and challenges.
    Kakaei N; Amirian R; Azadi M; Mohammadi G; Izadi Z
    Front Bioeng Biotechnol; 2023; 11():1115254. PubMed ID: 37600314
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ultrasound Triggered Tumor Oxygenation with Oxygen-Shuttle Nanoperfluorocarbon to Overcome Hypoxia-Associated Resistance in Cancer Therapies.
    Song X; Feng L; Liang C; Yang K; Liu Z
    Nano Lett; 2016 Oct; 16(10):6145-6153. PubMed ID: 27622835
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spontaneous Nucleation of Stable Perfluorocarbon Emulsions for Ultrasound Contrast Agents.
    Li DS; Schneewind S; Bruce M; Khaing Z; O'Donnell M; Pozzo L
    Nano Lett; 2019 Jan; 19(1):173-181. PubMed ID: 30543289
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phase-shift, stimuli-responsive perfluorocarbon nanodroplets for drug delivery to cancer.
    Rapoport N
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2012; 4(5):492-510. PubMed ID: 22730185
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Perfluorocarbon emulsion improves oxygen transport of normal and sickle cell human blood in vitro.
    Torres Filho IP; Pedro JR; Narayanan SV; Nguyen NM; Roseff SD; Spiess BD
    J Biomed Mater Res A; 2014 Jul; 102(7):2105-15. PubMed ID: 23894124
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Perfluorocarbon emulsions radiosensitise brain tumors in carbogen breathing mice with orthotopic GL261 gliomas.
    Feldman LA; Fabre MS; Grasso C; Reid D; Broaddus WC; Lanza GM; Spiess BD; Garbow JR; McConnell MJ; Herst PM
    PLoS One; 2017; 12(9):e0184250. PubMed ID: 28873460
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Perfluorocarbon-based oxygen carriers: from physics to physiology.
    Jägers J; Wrobeln A; Ferenz KB
    Pflugers Arch; 2021 Feb; 473(2):139-150. PubMed ID: 33141239
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Understanding the fundamentals of perfluorocarbons and perfluorocarbon emulsions relevant to in vivo oxygen delivery.
    Riess JG
    Artif Cells Blood Substit Immobil Biotechnol; 2005; 33(1):47-63. PubMed ID: 15768565
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.